A narrative review of studies comparing efficacy and safety of citalopram with atypical antipsychotics for agitation in behavioral and psychological symptoms of dementia (BPSD)

Keyphrases

• Agitation 100%
• Narrative Review 100%
• Atypical Antipsychotics 100%
• Citalopram 100%
• Neuropsychiatric Symptoms of Dementia 100%
• Selective Serotonin Reuptake Inhibitors 40%
• Randomized Controlled Trial 30%
• Antipsychotics 30%
• Psychomotor Agitation 20%
• Inhibitor Treatment 20%
• Treatment Methods 10%
• Placebo 10%
• Management Strategy 10%
• Low Risk 10%
• Adverse Effects 10%
• Meta-analysis 10%
• Long-term Efficacy 10%
• English Language 10%
• PubMed 10%
• Pharmacological Intervention 10%
• Aged Care Facilities 10%
• Prescribers 10%
• Long-term Safety 10%
• Medical Outcomes 10%
• Cochrane 10%
• Olanzapine 10%
• Dementia Patients 10%
• Systematic Meta-analysis 10%
• Inadequate Management 10%
• Retrieving Information 10%
• Justifiability 10%
• Quetiapine 10%
• Risperidone 10%
• Poor Functional Outcome 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Atypical Antipsychotics 100%
• Citalopram 100%
• Selective Serotonin Reuptake Inhibitor 80%
• Randomized Controlled Trial 60%
• Restlessness 40%
• Typical Antipsychotic 40%
• Antipsychotic 20%
• Olanzapine 20%
• Risperidone 20%
• Placebo 20%
• Psychotropic Agent 20%
• Adverse Event 20%
• Side Effect 20%
• Quetiapine 20%